Latest News
Nvidia and AMD are two great semiconductor stocks to buy and hold for the long term.
Via The Motley Fool · October 4, 2026
This nuclear company boasts a strong moat and should benefit from growing support for nuclear energy.
Via The Motley Fool · October 4, 2026
Immix Biopharma (NASDAQ:IMMX) reported updated clinical data for NXC-201, its investigational CAR T-cell therapy for relapsed or refractory light-chain (AL) amyloidosis, and outlined plans for a biologics license application, a frontline study and a targeted commercial launch strategy.
AL amyloidos
Via MarketBeat · October 4, 2026
Semiconductor maker Penguin Solutions (NASDAQ:PENG) will be reporting earnings this Tuesday after market hours. Here’s what you need to know. Penguin Solutio...
Via StockStory · October 4, 2026
Beer, wine, and spirits company Constellation Brands (NYSE:STZ) will be reporting results this Tuesday after the bell. Here’s what you need to know. Constell...
Via StockStory · October 4, 2026
Life sciences company Neogen (NASDAQ:NEOG) will be announcing earnings results this Tuesday after market hours. Here’s what to expect. Neogen beat analysts’ ...
Via StockStory · October 4, 2026
Architectural products company Apogee (NASDAQ:APOG) will be reporting results this Tuesday morning. Here’s what investors should know. Apogee beat analysts’ ...
Via StockStory · October 4, 2026
Potato products company Lamb Weston (NYSE:LW) will be announcing earnings results this Tuesday morning. Here’s what investors should know. Lamb Weston beat a...
Via StockStory · October 4, 2026
Peter Thiel has scored some big wins as a tech investor and company founder, but that doesn't mean everything he touches will turn to gold.
Via The Motley Fool · October 4, 2026
HPE stock soared last month on booming AI data center demand. Here's what drove the rally and why the enterprise computing giant's valuation still looks reasonable.
Via The Motley Fool · October 4, 2026
Invivyd (NASDAQ:IVVD) reported topline results from its Phase III LIBERTY study of VYD2311, an investigational low-dose intramuscular monoclonal antibody designed to prevent COVID-19, and outlined plans to pursue an accelerated-approval pathway with the U.S. Food and Drug Administration.
The compan
Via MarketBeat · October 4, 2026
Don't get your hopes up.
Via The Motley Fool · October 4, 2026
Lockheed Martin owned fifth-generation fighter jets. The sixth generation, however, belongs to Boeing.
Via The Motley Fool · October 4, 2026
The EV maker's growth year looks nearly certain -- but is it enough to justify the stock's price?
Via The Motley Fool · October 4, 2026
Micron is seeing surging revenue and earnings growth.
Via The Motley Fool · October 4, 2026
Broadcom's revenue has nearly doubled since late 2024, while Intel's has stalled — a widening gap that raises questions about competitive positioning.
Via The Motley Fool · October 4, 2026
Netflix may be a market laggard lately, but that should not make you lose sight of the long-term opportunity.
Via The Motley Fool · October 4, 2026
Don't bank on a Nike comeback. Both its quarterly results and guidance were terrible.
Via The Motley Fool · October 4, 2026
MercadoLibre recently surpassed Coupang in quarterly revenue for the first time, marking a pivotal shift in their competitive positioning.
Via The Motley Fool · October 4, 2026
Integra Resources (NYSEAMERICAN:ITRG) outlined plans to expand production from its Florida Canyon mine in Nevada while advancing its DeLamar and Nevada North development projects, positioning the company to grow from a current single-asset producer into a larger U.S.-focused gold producer.
The comp
Via MarketBeat · October 4, 2026
Bond yields are rising fast; the market looks expensive. A bear could be on the way. Consider buying Berkshire Hathaway, Realty Income, and Progressive.
Via The Motley Fool · October 4, 2026
A 27% cut in construction costs makes a solid sales pitch. But will it get the orders the stock already expects?
Via The Motley Fool · October 4, 2026
PolyPid (NASDAQ:PYPD) is approaching a November 28 PDUFA date for D-PLEX100, its lead product candidate for preventing surgical site infections in patients undergoing colorectal surgery, Chief Executive Officer Dikla Czaczkes Akselbrad said during the Lytham Partners Fall 2026 Investor Conference.
Via MarketBeat · October 4, 2026
Novo Nordisk covers its dividend, and Pfizer doesn't, but investors appear increasingly worried about Novo's future.
Via The Motley Fool · October 4, 2026
Liberty Gold (TSE:LGD) outlined plans to advance its Black Pine oxide gold project in southeast Idaho following completion of a feasibility study, with the company targeting detailed engineering completion by the third quarter of 2027 and commercial production in 2029.
During a company presentation
Via MarketBeat · October 4, 2026